Christian Rothermundt, Alexandra Bailey, Linda Cerbone, Tim Eisen, Bernard Escudier, Silke Gillessen, Viktor Grünwald, James Larkin, David McDermott, Jan Oldenburg, Camillo Porta, Brian Rini, Manuela Schmidinger, Cora Sternberg, Paul M Putora
BACKGROUND: With the advent of targeted therapies, many treatment options in the first-line setting of metastatic clear cell renal cell carcinoma (mccRCC) have emerged. Guidelines and randomized trial reports usually do not elucidate the decision criteria for the different treatment options. In order to extract the decision criteria for the optimal therapy for patients, we performed an analysis of treatment algorithms from experts in the field. MATERIALS AND METHODS: Treatment algorithms for the treatment of mccRCC from experts of 11 institutions were obtained, and decision trees were deduced...
September 2015: Oncologist